Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.
Press releases published on May 22, 2025
Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
GlobeNewswire
·
May 22, 2025
Daix, May 22, 2025 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of this description is to present the objectives and terms of the Company’s share repurchase program approved …
Descriptif du Programme de Rachat d’Actions Pouvant Être Mis en Œuvre dans le Cadre du Contrat de Liquidité Conclu avec Kepler Chevreux
GlobeNewswire
·
May 22, 2025
Daix, le 22 mai 2025 En application de l'article 241-2 du Règlement Général de l’Autorité des marchés financiers (AMF), le présent descriptif a pour finalité de présenter les objectifs ainsi que les modalités du programme de rachat d’actions autorisé par l …
Sofwave to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Assaf Korner, Chief …
Avalyn to Participate in the Jefferies Global Healthcare Conference in June
GlobeNewswire
·
May 22, 2025
CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the …
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate …
GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results
GlobeNewswire
·
May 22, 2025
Data presented at the 2025 American Thoracic Society (ATS) International Conference Pre-clinical and interim clinical results underscore GRI-0621’s potential to have both anti-inflammatory and anti-fibrotic effects in pulmonary fibrosis Results from 6-week …
Eight recipients honoured with the 2025 Fiera Capital Awards for Diversity, Equity, and Inclusion in Health Care Research
GlobeNewswire
·
May 22, 2025
MONTREAL, May 22, 2025 (GLOBE NEWSWIRE) -- This year, eight exceptional medical and health science students from Black, Indigenous, and other racialized communities have been awarded the 2025 Fiera Capital Awards for Diversity, Equity, and Inclusion in …
Huit jeunes talents honorés lors des Prix Fiera Capital 2025 pour la diversité, l’équité et l’inclusion dans la recherche en santé
GlobeNewswire
·
May 22, 2025
MONTRÉAL, 22 mai 2025 (GLOBE NEWSWIRE) -- Cette année, huit étudiants et étudiantes d’exception en médecine et en sciences de la santé issu(e)s des communautés noires, autochtones et autres groupes racisés ont reçu les Prix Fiera Capital 2025 pour la …
Sequel Med Tech to Integrate twiist Automated Insulin Delivery (AID) System with Abbott’s Future Dual Glucose-Ketone Sensor
GlobeNewswire
·
May 22, 2025
MANCHESTER, N.H., May 22, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies today announced a commercial development agreement for future integration of Sequel’s twiist™ Automated Insulin …
Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 22, 2025
PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a …
Sagimet Biosciences to Host Virtual KOL Event, “Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)” on May 29, 2025
GlobeNewswire
·
May 22, 2025
SAN MATEO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced it will host a …
Stratus Announces Publication of Stratus PRIME™ HSC Platform in the American Journal of Hematology
GlobeNewswire
·
May 22, 2025
First-in-class approach enables the generation of transgene-free hematopoietic stem cells through mechanosensitive PIEZO1 activation Stratus has an exclusive license to the intellectual property for the platform technology – Stratus Prime™ CAMBRIDGE, Mass …
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
GlobeNewswire
·
May 22, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Telix to Host Investor Day in New York City on June 11, 2025
GlobeNewswire
·
May 22, 2025
MELBOURNE, Australia and INDIANAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, …
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
GlobeNewswire
·
May 22, 2025
MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as the "Company" or “PetVivo”) an emerging biomedical device …
Introducing Y'all's Beer: A True Taste of Texas from Revolver Brewing
GlobeNewswire
·
May 22, 2025
GRANBURY, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Revolver Brewing, a craft beer pioneer in North Texas and craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), known for crafting bold and uniquely Texan beers, is proud to unveil its …
Repligen Corporation to Present at William Blair Growth Conference
GlobeNewswire
·
May 22, 2025
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the William Blair 45th Annual Growth Stock …
InflaRx to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 22, 2025
JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor …
Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
GlobeNewswire
·
May 22, 2025
Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects. Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller at …
Aurora Spine Corporation Announces Record First Quarter Financial Results
GlobeNewswire
·
May 22, 2025
- Company to host conference call Today, Thursday, May 22nd at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or …